The role of chemotherapy in early-stage (stage I and II) resectable non-small cell lung cancer.
Explore this paper's citation graph
Summary
A meta-analysis examining the role of chemotherapy in the treatment of NSCLC found a 5% absolute improvement in 5-year survival associated with the use of adjuvant cisplatin-based chemotherapy (P =.08).
- Type
- article
- Published
- 2000-10-01
- Cited by
- 14
- References
- 23
- OpenAlex
- https://openalex.org/W11040327
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:21415452
Keywords
Polar, Electron, Physics, Astrobiology, Astronomy
References
- Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: a randomized study.
- Lung cancer : progress in therapeutic research
- Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery.
- Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.
- Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public.
- 1053 Phase III study of neo-adjuvant chemotherapy in resectable non-small cell lung cancer (NSCLC)
- Bronchogenic carcinoma: Nitrogen mustard as a surgical adjuvant and factors influencing survival. University surgical adjuvant lung project
- Retrospective and prospective tumor staging evaluating prognostic factors in operated bronchus carcinoma patients
- Revisions in the International System for Staging Lung Cancer.
- Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group.
- Prospective randomized trial of postoperative adjuvant therapy in patients with completely resected stages II and IIIa non-small cell lung cancer: An intergroup trial (E3590)
- Prolonged intermittent adjuvant chemotherapy with CCNU and hydroxyurea after resection of carcinoma of the lung
- Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial.
- Lung cancer classification: The relationship of disease extent and cell type to survival in a clinical trials population
- Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma.
- Incidence of local recurrence and second primary tumors in resected stage I lung cancer.
- Cancer statistics, 2000
- Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team.
- Frequency of residual and metastatic tumor in patients undergoing curative surgical resection for lung cancer.
- Surgical adjuvant therapy for stage II and stage III adenocarcinoma and large-cell undifferentiated carcinoma.
Cited by
- Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial.
- Prognostic impact of Cyfra21-1 and other serum markers in completely resected non-small cell lung cancer.
- Resected non-small-cell lung cancer stage I/II: indication for adjuvant/neoadjuvant therapy?
- The Ki‐67 Index and Survival in Non‐‐‐Small Cell Lung Cancer: A Review and Relevance to Positron Emission Tomography
- Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung.
- Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
- Place de la gemcitabine dans les traitements combinationés de radiothérapie- chimiothérapie du cancer bronchique non a petites cellules de stade III
- Survival and prognostic factors in resected cN2-pN0 non-small cell lung cancer.
- Results of induction chemotherapy followed by surgical resection in patients with stage IIIA (N2) non-small cell lung cancer: the importance of the nodal down-staging after chemotherapy.
- Gefitinib: phase II and III results in advanced non-small cell lung cancer.
- Intensity-Modulated Radiation Therapy and Volumetric-Modulated Arc Therapy for Lung Cancer
- Abstract. Although antibodies targeting the immune check‐ point protein programmed death‐1 (PD‐1) exert therapeutic effects in patients with primary or metastatic non‐small cell
- Survival and Prognostic Factors in Resected cN 2-pN 0 Non-small Cell Lung Cancer
Related papers
- Interaction of thermal electrons with polar molecules
- On the nature of solvated electrons in polar fluids
- Excess Electrons in Polar Solvents
- Snowballing effect for electron solvation in dilute solutions of polar molecules in nonpolar solvents
- Microdipole model for trapped electrons in nonpolar liquids and glassy solids
- Towards a quantum gas of polar YbCs molecules